About Us
China Medical System Holdings Limited (“CMS” or the “Group”, stock code: 867.HK) is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet healthcare needs. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong Limited since 28 September 2010, and included in the Morgan Stanley Capital International (MSCI) Global Small Cap Indexes – China Index, Hang Seng Healthcare Index and Hang Seng Innovative Drug Index, etc. The Group is the object of transaction in both Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect. CMS has been ranked “A” or “AA” in MSCI-ESG ratings in the latest three years.
